Li Chun-zhi, Sun Mo-yi, Zhang Xiao-hui, Luo Xiao-long, Sun Wen-bin
Department of Oral and Maxillofacial Surgery, The 251th Hospital of PLA, Zhangjiakou Hebei 075000, China.
Zhonghua Kou Qiang Yi Xue Za Zhi. 2006 Dec;41(12):709-12.
The pathologic slides and clinical data of 119 patients with mucoepidermoid carcinoma (MEC) of salivary glands were reviewed. All patients underwent surgical therapy in Department of Oral and Maxillofacial Surgery, College of Stomatology, Fourth Military Medical University. The postoperative overall observed survival rates and specific survival rates were statistically caculated, and the correlative clinicopathologic factors influencing the prognosis were evaluated.
Statistical analysis was performed using the SPSS 10.0 software. The survival rates were obtained by the Kaplan-Meier method. The clinicopathologic parameters were evaluated using log rank test (univariate analysis) and Cox proportional hazards regression model (multivariate analysis).
The overall observed survival rates of this group were 92.53%, 87.52% and 85.39% at 5, 10 and 15 years respectively after surgical therapy. Univariate analysis demonstrated that the factors correlated with lower in survival rates were patient's age (> or = 40 years), advanced clinical stage (TNM III, IV stage) and the poorly differentiated tumors (P < 0.05). The survival rates of male patients with MEC in the major salivary glands were significantly lower than those of female patients (P = 0.008). The degree of differentiation, TNM stage and preoperative symptoms were three important prognostic factors that were selected into the Cox proportional hazards regression model.
Most patients with highly differentiated MEC in salivary glands had a favorable outcome after receiving adequate surgical treatment. The degree of differentiation and the TNM stage of MEC in the salivary glands are two useful factors to evaluate the prognosis of these neoplasms.
回顾性分析119例涎腺黏液表皮样癌(MEC)患者的病理切片及临床资料。所有患者均在第四军医大学口腔医学院口腔颌面外科接受手术治疗。统计术后总生存率和特异性生存率,并评估影响预后的相关临床病理因素。
采用SPSS 10.0软件进行统计学分析。生存率采用Kaplan-Meier法计算。临床病理参数采用对数秩检验(单因素分析)和Cox比例风险回归模型(多因素分析)进行评估。
该组患者术后5年、10年和15年的总生存率分别为92.53%、87.52%和85.39%。单因素分析显示,与生存率降低相关的因素为患者年龄(≥40岁)、临床分期较晚(TNMⅢ、Ⅳ期)及肿瘤分化差(P<0.05)。大涎腺MEC男性患者的生存率显著低于女性患者(P=0.008)。分化程度、TNM分期和术前症状是被纳入Cox比例风险回归模型的三个重要预后因素。
大多数涎腺高分化MEC患者在接受充分手术治疗后预后良好。涎腺MEC的分化程度和TNM分期是评估这些肿瘤预后的两个有用因素。